Celestone Chronodose 5,7 mg/ml
Let op: dit is een geneesmiddel, geregistreerd voor humaan gebruik!
De administratieve eisen voor een dierenarts zijn vermeld in art. 5.1 - 5.4. van de Besluit diergeneeskundigen.
Celestone Chronodose 5,7 mg/ml
Description
Each mL of Celestone Chronodose Injection contains betamethasone 5.7 mg, as betamethasone sodium phosphate 3.9 mg (in solution) and betamethasone acetate 3 mg (in suspension) in an aqueous vehicle.
Pharmacology
Celestone Chronodose is an injectable preparation containing both soluble and slightly soluble esters of betamethasone that provides anti-inflammatory, anti-rheumatic and antiallergic effects in the treatment of corticosteroid-responsive disorders. Prompt therapeutic activity in conditions responsive to corticosteroids is initiated by betamethasone sodium phosphate, a soluble ester that is absorbed quickly into tissues after injection. Sustained activity is provided by betamethasone acetate, which is only slightly soluble and affords a repository for slow absorption. The combined rapid and depot actions of these forms of betamethasone facilitate rapid control as well as steady maintenance of corticosteroid effects.
| Art.nr. | MON001 |
|---|---|
| Registratienummer | Human |
| Merk | MSD Intervet |
| Koelproduct | Nee |
| Actief Ingredient | Betamethasone |
| Legal status of supply | POM |
| Units per outer box | 0 |